Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Study ID: NCT06320951
Start Date: 2026-12-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Vericiguat 10 MG

Placebo

Insulin Sensitivity Test

Resting Energy and Exercise Energy Expenditure Assessment

White Adipose Tissue Biopsy

MRI-PET Scan for Brown Adipose Tissue Volume Assessment

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

Study ID: NCT06545695
Start Date: 2027-07-01
End Date: 2031-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

44

Intervention / Treatment

Erlotinib

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension

Study ID: NCT06176118
Start Date: 2026-05-01
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

2-BECAUSE

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Magnetic Ressonance Imaging of Temporomandibular Joint

Study ID: NCT02294799
Start Date: 2026-08
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Intervention Group

Placebo group

Sponsor

Daniela Ap. Biasotto-Gonzalez

Source: clinicaltrials.gov

Share:
Add to list

A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors

Study ID: NCT05453851
Start Date: 2026-07-01
End Date: 2030-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

Pancreatectomy

Quality-of-Life Assessment

Treatment Planning

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

Study ID: NCT07333066
Start Date: 2026-03-31
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

320

Intervention / Treatment

Apalutamide (Erleada™) 60 mg or 240 mg tablets

Docetaxel

Sponsor

Multidisciplinary alliance for research into genitourinary tumors -GUARD

Source: clinicaltrials.gov

Share:
Add to list

Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

Study ID: NCT07312786
Start Date: 2026-04
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

virtual self-management intervention

Sponsor

Nova Scotia Health Authority

Source: clinicaltrials.gov

Share:
Add to list

The Remote Monitoring of Gout Feasibility Study in Primary Care

Study ID: NCT07490522
Start Date: 2026-04
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Patient self-management app 'MinUrinsyregikt'

Sponsor

Diakonhjemmet Hospital

Source: clinicaltrials.gov

Share:
Add to list

Behavioral Economics to Implement Nutrition Ranking in Food Pantries

Study ID: NCT05854212
Start Date: 2027-01-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

364

Intervention / Treatment

Behavioral economics-enhanced user interface

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Study ID: NCT07137481
Start Date: 2027-02-28
End Date: 2032-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

C9/CD5CAR/IL-15 NK cells

Rituximab

Fludarabine

Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list